ANDA 86893, held by Lederle. Chlordiazepoxide Hydrochloride.
As of Nov 16, 2026, ANDA 86893 (Chlordiazepoxide Hydrochloride), held by Lederle, was not approved, with 3 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlordiazepoxide Hydrochloride25MG ยท capsule;oral | Chlordiazepoxide Hydrochloride | Discontinued |
| Jul 8, 1982 | Supplement 1Manufacturing | Approved | None posted |
| Jul 8, 1982 | Supplement 2Manufacturing | Approved | None posted |
| Jul 8, 1982 | Supplement 3Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters